Wipro Ge Medical Device Manufacturing Profile
Key Indicators
- Authorised Capital ₹ 2.15 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 355.19%
(FY 2023)
- Ebitda 994.69%
(FY 2023)
- Net Worth 323.53%
(FY 2023)
- Total Assets 70.48%
(FY 2023)
About Wipro Ge Medical Device Manufacturing
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.15 Cr and a paid-up capital of Rs 2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Wipro Ge Medical Device Manufacturing Private Limited India is Manjunath Hegde as COMPANY SECRETARY. Ayush Gupta and Dheenadhayalan Krishnamoorthy serve as directors at the Company.
- CIN/LLPIN
U33110KA2020FTC140129
- Company No.
140129
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
23 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Wipro Ge Medical Device Manufacturing?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dheenadhayalan Krishnamoorthy | Managing Director | 05-Nov-2024 | Current |
Manjunath Hegde  | Company Secretary | 11-Mar-2023 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayush Gupta | Director | 30-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Wipro Ge Medical Device Manufacturing.
Wipro Ge Medical Device Manufacturing Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 355.19% increase in profit. The company's net worth Soared by an impressive increase of 323.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wipro Ge Medical Device Manufacturing?
In 2023, Wipro Ge Medical Device Manufacturing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wipro Ge Medical Device Manufacturing?
Wipro Ge Medical Device Manufacturing has a workforce of 52 employees as of Aug 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wipro Ge Medical Device Manufacturing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wipro Ge Medical Device Manufacturing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
